Isn't NS Pharma (subsidiary of Japanese company Nippon Shinyaku) the company that has made the Agreement with Capricor for the distribution/sales of Capricors' potential DMD cure for which Capricor has received $30 million to help finance the completion of their research with more to be provided if required - i.e. our competitor ?
Combo Data, page-35
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $10.76K | 104.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 532750 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 286603 | 3 |
View Market Depth
| Last trade - 11.08am 10/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |